Skip to main content
Trending
Zaporizhzhia plantPlanetary defenseSouth korea economyCircuit splitsWi-fi 8 hardwarePhotosynthesis limitsMarket strategyHvac codeAssessment reformProduction economicsNetwork theoryNetwork strategyMetabolic scienceSpace-based sigintManagerial shiftAviation safetyBrake architectureData structuresOffice softwareTitle riskExercise physiologyChart geometryCooking methodsLihtc paradoxNetwork architectureIndex mechanicsBiodiversity lossSelf-healing concreteCinema technologyCritical minerals

Mental Health

All HealthNutrition & DietSupplementsMental HealthSleepLongevityMedicineMedications & TreatmentsConditions & DiseasesHormones & EndocrinologySkincareDental HealthFamily HealthChildren's HealthMen's HealthWomen's HealthAging & GeroscienceBiohackingAlternative MedicinePublic HealthMedical ResearchPreventive WellnessHealthy Habits
Explainer

Oral Semaglutide Fails to Slow Early Alzheimer's Decline in Phase 3 Trials

4 sources · 15d ago

Research Brief

Landmark Review Identifies Best Drug and Non-Drug Treatments for Bipolar Disorder Across All Mood Phases

5 sources · 16d ago

Explainer

FDA Approves Cobenfy, First Non-Dopamine Antipsychotic for Schizophrenia

5 sources · 18d ago

More in Mental Health

ExplainerPrecision Psychiatry

Landmark Study Finds Biomarker-Guided Antidepressant Selection Boosts Response Rates by 67%

Precision Psychiatry Researchers 40%Clinical Pragmatists 40%Patient Advocates 20%

2 sources · 19d ago

ExplainerADHD Treatment

FDA Approves Simtriyo, First-in-Class NDSRI Drug for ADHD in Adults and Children

Clinical Researchers & Regulators 40%Industry & Market Analysts 30%Patient & Clinical Care Advocates 30%

6 sources · 20d ago

ExplainerPsychedelic Medicine

Phase 3 Trial Shows Psychedelic-Derived DT120 Achieves Rapid Remission for Generalized Anxiety Disorder

Neuroplasticity Advocates 45%Regulatory Optimists 30%Traditional Psychedelic Therapists 25%

4 sources · 22d ago

ExplainerNeuromodulation

Personalized, Accelerated TMS Therapy Achieves Depression Remission in Days, Not Months

Clinical Researchers 40%Patient Access Advocates 35%Health Economists 25%

3 sources · 24d ago

ExplainerAddiction Medicine

Landmark Study Links GLP-1 Drugs to Reduced Risk of Alcohol, Opioid, and Nicotine Addiction

Addiction Medicine Researchers 40%Public Health Officials 35%Clinical Skeptics 25%

4 sources · 27d ago

ExplainerTeen Screen Time

The 3-Hour Threshold: What the Evidence Actually Says About Teen Social Media Use

Public Health Researchers 44%Clinical Practitioners 33%Media & Public Watchdogs 22%

8 sources · 29d ago

Research BriefNeurology Research

Motor Neurone Disease Trials Yield 'Huge Breakthrough' in Slowing Progression, Though Cure Remains Distant

Clinical Researchers 45%Patient Advocacy Groups 35%Evidence Analysts 20%

6 sources · 31d ago

Blindspot

Important stories the mainstream barely covered

High-impact news with only 1–3 outlets covering it. These stories matter — they just didn't make the radar.

All blindspots →
health

Landmark Global Study Finds Distinct 'Metabo-Psychiatric' Genetic Profiles for Binge Eating and Anorexia Nervosa

A massive genomic analysis has mapped the distinct genetic signatures of binge eating and anorexia nervosa, confirming that eating disorders are driven by a complex mix of psychiatric and metabolic biology.

Psychiatric Geneticists 35%Clinical Researchers 35%Patient Advocates 30%
ai

China Mandates Shutdown of AI Companion Services Over 'Emotional Dependency' Concerns

New federal regulations in China have forced major tech platforms to disable custom AI personas, citing the psychological risks of human-computer attachment. The rules ban virtual intimate relationships for minors and require real-time distress intervention for all users.

Chinese Regulatory Authorities 40%AI Companion Users 30%Global Tech Policy Analysts 30%

Explore more topics

News & PoliticsWorldBusinessFinanceTechnologyArtificial IntelligenceScienceEnergy